TY - JOUR
T1 - Intra-arterial chemotherapy for retinoblastoma
T2 - Our first experience in Indonesia
AU - Sidipratomo, Prijo
AU - Pandelaki, Jacub
AU - Matondang, Sahat B.R.E.
AU - Ramandika, Heltara
AU - Sitorus, Rita Sita
AU - Karismaputri, Komang S.
AU - Anindyagari,
N1 - Funding Information:
The authors thank Albert Novianto, MD, Alvyn Yeremia Pribadi, MD, Rizky Nugroho, MD, and Jason for their assistance in writing the manuscript.
Publisher Copyright:
© 2022
PY - 2022/12
Y1 - 2022/12
N2 - Intra-arterial chemotherapy (IAC) has become the mainstay therapy for retinoblastoma group D and E for the past few decades. However, IAC had never been done in Indonesia before. In this report, we present a case of a 2-year-old girl with recurrent Group D retinoblastoma of the left eye that improved significantly after one session of IAC, the first IAC in Indonesia.
AB - Intra-arterial chemotherapy (IAC) has become the mainstay therapy for retinoblastoma group D and E for the past few decades. However, IAC had never been done in Indonesia before. In this report, we present a case of a 2-year-old girl with recurrent Group D retinoblastoma of the left eye that improved significantly after one session of IAC, the first IAC in Indonesia.
KW - Intra-arterial chemotherapy
KW - Melphalan
KW - Retinoblastoma
UR - http://www.scopus.com/inward/record.url?scp=85139357042&partnerID=8YFLogxK
U2 - 10.1016/j.radcr.2022.09.004
DO - 10.1016/j.radcr.2022.09.004
M3 - Article
AN - SCOPUS:85139357042
SN - 1930-0433
VL - 17
SP - 4713
EP - 4716
JO - Radiology Case Reports
JF - Radiology Case Reports
IS - 12
ER -